Picture of Solid Biosciences logo

SLDB Solid Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Solid Biosciences Inc expected to post a loss of 64 cents a share - Earnings Preview

* Solid Biosciences Inc  SLDB.OQ   SLDB.O  is expected
to show a
rise in quarterly revenue when it reports  results on May 9
(estimated) for the period ending March 31 2024
    * The Charlestown Massachusetts-based  company is expected
to
report revenue of $1.208 million, according to the mean estimate
from 6 analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Solid Biosciences Inc is
for a
loss of 64 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Solid
Biosciences
Inc is $16.50​, above​ its last closing price of $10.00. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -1.04       -0.99      -1.00     Missed  -1.2
 Sep. 30 2023  -1.19       -1.19      -1.05     Beat    11.6
 Jun. 30 2023  -1.55       -1.53      -1.25     Beat    18.6​
 Mar. 31 2023  -2.21       -2.05      -1.50     Beat    26.9
 ​​Dec.                    -1.65      -2.82     Missed  -70.7
 31 2022                                                
 Sep. 30 2022  -2.57       -2.67      -2.71     Missed  -1.5​
 Jun. 30 2022  -3.07       -3.15      -3.30     Missed  -4.8
 Mar. 31 2022  -2.77       -2.76      -3.30     Missed  -19.6
 This summary was machine generated May 7 at 12:43 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Solid Biosciences

See all news